Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma. Wang M, Salek D, Belada D, Song Y, et al. J Clin Oncol 2025 May 1:101200JCO2500690. doi: 10.1200/JCO-25-00690.

Read + Share

Amedeo Smart

Independent Medical Education

Wang M, Salek D, Belada D, Song Y, et al. Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma. J Clin Oncol 2025 May 1:101200JCO2500690. doi: 10.1200/JCO-25-00690.
PMID: 40311141